• 1
    Lewis NR, Scott BB. Systematic review: the use of serology to exclude or diagnose celiac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 2006; 24: 4754.
  • 2
    Bardella MT, Franquelli M, Quatrini M, Molteni N, Bianchi P, Conte D. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology 1995; 22: 8336.
  • 3
    Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology 2007; 46: 16508.
  • 4
    Volta U, De Franceschi L, Lari F, Molinaro N, Zoli M, Bianchi F. Celiac diseases hidden by cryptogenic hypertransaminasemia. Lancet 1998; 352: 269.
  • 5
    Bardella MT, Vecchi M, Conte D, et al. Chronic unexplained hypertransaminasemia may be cause by occult celiac disease. Hepatology 1999; 29: 6547.
  • 6
    Ludvigsson JF, Elfstrom P, Broome U, Ekbom A, Montgomery SM. Celiac disease and risk of liver disease: a general population based-study. Clin Gastroenterol Hepatol 2007; 5: 639.
  • 7
    Sorensen HT, Thulstrup AM, Blomqvist P, Norgaard B, Fonager K, Ekbom A. Risk of primary biliary liver cirrhosis in patients with celiac disease: Danish and Sweedish cohort study. Gut 1999; 44: 7368.
  • 8
    Lawson A, West J, Aithal GP, Logan RF. Autoimmune cholestatic liver disease in people with celiac disease: a population-based study of their association. Aliment Pharmacol Ther 2005; 21: 4015.
  • 9
    Niveloni S, Dezi R, Pedreira S, et al. Gluten sensitivity in patients with primary biliary cirrhosis. Am J Gastroenterol 1998; 93: 4048.
    Direct Link:
  • 10
    Floreani A, Betterle C, Baragiotta A, et al. Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis 2002; 34: 24850.
  • 11
    Kingham JGC, Parker DR. The association between primary biliary cirrhosis and celiac disease: a study of relative prevalences. Gut 1998; 42: 1202.
  • 12
    Volta U, De Franceschi L, Molinaro N, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 1998; 43: 21905.
  • 13
    Villalta D, Girolami D, Bidoli E, et al. High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue transglutaminase autoantibodies. J Clin Lab Anal 2005; 19: 610.
  • 14
    Germenis AE, Yiannaki EE, Zachou K, et al. Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clin Diagn Lab Immunol 2005; 12: 9418.
  • 15
    Volta U, Rodrigo L, Granito A, et al. Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol 2002; 97: 260913.
    Direct Link:
  • 16
    Rubio-Tapia A, Abdulkarim AS, Wiesner RH, Moore SB, Krause PK, Murray JA. Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int 2008; 28: 46473.
  • 17
    Goerres MS, Meijer JW, Wahab PJ, et al. Azathioprine and prednisone combination therapy in refractory celiac disease. Aliment Pharmacol Ther 2003; 18: 48794.
  • 18
    Al-Toma A, Verbeek WH, Hadithi M, Von Blomberg BM, Mulder CJ. Survival in refractory celiac disease and enteropathy associated T cell lymphoma: retrospective evaluation of single center experience. Gut 2007; 56: 13738.